US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SGS SA

11.54

-0.0600-0.52%

Volume:41.91K

Turnover:482.80K

Market Cap:22.34B

PE:35.16

High:11.58

Open:11.41

Low:11.38

Close:11.60

52wk High:12.76

52wk Low:9.86

Shares:1.94B

Float Shares:1.57B

Volume Ratio:0.81

T/O Rate:0.00%

Dividend:0.39

Dividend Rate:3.41%

EPS(TTM):0.3282

EPS(LYR):0.3569

ROE:76.60%

ROA:8.41%

PB:20.14

PE(LYR):32.33

Loading ...

Overview Company News Filings

Earning Preview: SGS SA revenue is expected to be unchanged at 0%, and institutional views are limited

Press Release: SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.

Press Release: SGS Acquires Keystone Bioanalytical, Strengthening End-to-End Drug Development Lifecycle Testing Capabilities for North American Pharma and Biotech Industries

SGS Is Diverse But Sector Offers Better Opportunities -- Market Talk

SGS Might Hit 2027 Targets Early -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SGSOY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGSOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGSOY\",,,,,undefined,":{"symbol":"SGSOY","market":"US","secType":"STK","nameCN":"SGS SA","latestPrice":11.54,"timestamp":1784663909978,"preClose":11.6,"halted":0,"volume":41908,"delay":15,"changeRate":-0.005172413793103492,"floatShares":1572334822,"shares":1935656360,"eps":0.328235,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"07-21 15:58:29 EDT Delay","open":11.41,"high":11.5815,"low":11.38,"amount":482804.7368000002,"amplitude":0.017371,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.328235,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784678400000},"marketStatusCode":4,"adr":0,"adrRate":0.1,"exchange":"PINK LIMITED","adjPreClose":11.6,"volumeRatio":0.809232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGSOY\",,,,,undefined,":{"symbol":"SGSOY","floatShares":1572334822,"roa":"8.41%","roe":"76.60%","lyrEps":0.356914,"volumeRatio":0.809232,"shares":1935656360,"dividePrice":0.393833,"high":11.5815,"amplitude":0.017371,"preClose":11.6,"low":11.38,"week52Low":9.86,"pbRate":"20.14","psRate":"2.61","week52High":12.7599,"institutionHeld":0.0001,"latestPrice":11.54,"eps":0.328235,"divideRate":0.034128,"volume":41908,"delay":15,"ttmEps":0.328235,"open":11.41,"prevYearClose":11.39,"prevWeekClose":11.77,"prevMonthClose":11.57,"prevQuarterClose":11.57,"fiveDayClose":11.6,"twentyDayClose":11.04,"sixtyDayClose":10.78,"earningDate":1784822400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGSOY\",params:#limit:5,,,undefined,":[{"date":"2026-07-24","symbol":"SGSOY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784880000000,"name":null,"time":"","dateTimestamp":1784865600000,"actualEps":null},{"date":"2026-04-07","symbol":"SGSOY","amount":0.410835,"announcedDate":"2026-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-07","defaultRemindTime":1775568600000,"name":"SGS SA","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-07","currency":"USD","dateTimestamp":1775534400000,"payDate":"2026-05-11"},{"date":"2026-04-02","symbol":"SGSOY","amount":0.410835,"announcedDate":"2026-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-03","defaultRemindTime":1775136600000,"name":"SGS SA","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-03","currency":"USD","dateTimestamp":1775102400000,"payDate":"2026-05-11"},{"date":"2025-04-03","symbol":"SGSOY","amount":0.362976,"announcedDate":"2025-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-03","defaultRemindTime":1743687000000,"name":"SGS SA","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-09","payableDate":"2025-04-03","currency":"USD","dateTimestamp":1743652800000,"payDate":"2025-05-09"},{"market":"US","date":"2025-02-11","symbol":"SGSOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGSOY\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-26","recordDate":"2019-03-27","paymentDate":"2019-04-12","value":0.460368,"currency":"USD"},{"executeDate":"2020-03-26","recordDate":"2020-03-27","paymentDate":"2020-04-14","value":0.4841,"currency":"USD"},{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-13","value":0.528549,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":"2022-04-01","paymentDate":"2022-04-19","value":0.864304,"currency":"USD"},{"executeDate":"2023-03-30","recordDate":"2023-03-31","paymentDate":"2023-04-18","value":0.848806,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGSOY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1759982400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGSOY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191892459","title":"Earning Preview: SGS SA revenue is expected to be unchanged at 0%, and institutional views are limited","url":"https://stock-news.laohu8.com/highlight/detail?id=1191892459","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1191892459?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:00","pubTimestamp":1784253637,"startTime":"0","endTime":"0","summary":"Abstract SGS SA will release second-quarter 2026 results before-market on July 24, 2026, and this preview compiles the latest quarterly metrics, segment contributions, and scenario analysis for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: SGS SA revenue is expected to be unchanged at 0%, and institutional views are limited","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGSOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640188042","title":"Press Release: SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640188042","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640188042?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:30","pubTimestamp":1780500600,"startTime":"0","endTime":"0","summary":"\"North America is the largest global market for bioanalytical testing services, with demand for advanced, high-precision capabilities continuing to grow,\" said Joseph Bower, Head of Life Sciences at SGS in North America. \"With CMIC, INC. joining the SGS laboratory network, we are strengthening our ability to support drug development through high-quality bioanalytical data that demonstrate the safety and efficacy of complex molecule therapies, aligned with regulatory expectations. It is truly exciting to play a critical role behind the advancement of innovative therapies - from biologics to gene therapies - bringing them closer to patients.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGSOY","BK4123","INC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632954985","title":"Press Release: SGS Acquires Keystone Bioanalytical, Strengthening End-to-End Drug Development Lifecycle Testing Capabilities for North American Pharma and Biotech Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2632954985","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632954985?lang=en_us&edition=fundamental","pubTime":"2026-05-04 23:40","pubTimestamp":1777909200,"startTime":"0","endTime":"0","summary":"BLOOMFIELD, N.J., May 4, 2026 /CNW/ - SGS, the world's leading testing, inspection and certification company, is pleased to announce that it has acquired Keystone Bioanalytical, a specialized provider of bioanalytical testing services based in Philadelphia, Pennsylvania .\"Expanding our GLP--compliant, bioanalysis-focused capabilities within the SGS North American network underscores our commitment to meeting the growing demand for high--quality bioanalytical services supporting small and large molecule drug development,\" said Joseph Bower, Head of Life Sciences at SGS in North America. \"This is an exciting time for SGS as we keep pace with the momentum driving North American pharma and biotech companies to lead the way globally in bringing innovative medicines and therapies to market.\". In North America, stringent regulatory oversight by agencies such as the U.S. Food and Drug Administration and Health Canada is driving continued demand for high-quality bioanalytical testing services. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4107","BK4117","BK4123","BK4588","SGSOY","BK4585","BK4581","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629888274","title":"SGS Is Diverse But Sector Offers Better Opportunities -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2629888274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629888274?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:27","pubTimestamp":1776929220,"startTime":"0","endTime":"0","summary":"0727 GMT - While SGS is a highly diversified company, there are better opportunities across the wider sector, RBC Capital Markets analysts Karl Green and Andrew Brooke say in a research note. Headwinds are growing around the global trade outlook and some trends are weakening the testing, inspection and certification industry, the analysts add. Nevertheless, the Swiss company posted first-quarter revenue in line with consensus and backed its outlook, which should be taken reassuringly, they say. Shares trade 0.9% higher at 87.04 Swiss francs. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGSOY","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610983185","title":"SGS Might Hit 2027 Targets Early -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2610983185","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610983185?lang=en_us&edition=fundamental","pubTime":"2026-02-11 14:36","pubTimestamp":1770791760,"startTime":"0","endTime":"0","summary":"0635 GMT - SGS might hit its 2027 targets one year ahead of plan, as its 2025 results show it is making progress toward its objectives, Bernstein's Will Kirkness and Filippo Giardini say in a research note. The Swiss testing, inspection and certification company reported 2025 earnings that exceeded consensus expectations, with organic sales growth in line with views, the analysts say. It confirmed 2027 targets, including an improvement of at least 1.5 percentage points in adjusted operating profit margin, but said it is on track to exceed them. \"The proposed [capital markets day] before the end of 2026 suggests that the reiterated 2027 strategy could be achieved a year ahead of plan--16.2% margin--with strong progress also seen in growing sustainability, digital trust and North America revenues,\" the analysts say. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","SGSOY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}